Zhejiang Haisen Pharmaceutical Co., Ltd. reported earnings results for the full year ended December 31, 2023. For the full year, the company reported sales was CNY 397.45 million compared to CNY 422.78 million a year ago. Net income was CNY 104.67 million compared to CNY 107.59 million a year ago.

Basic earnings per share from continuing operations was CNY 1.68 compared to CNY 2.11 a year ago. Diluted earnings per share from continuing operations was CNY 1.68 compared to CNY 2.11 a year ago.